Clarion, Janea B.

HRN: 27-51-60  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/13/2025
CEFUROXIME 750MG (VIAL)
08/13/2025
08/20/2025
IV DRIP
130 Mg
Q8h
T/c Intussusception
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: